HIVR4P2024: Lenacapavir brings hope to ending HIV epidemic, says Dr Colleen Kelley

By Avit Ndayiziga Nicknamed a miracle HIV prevention tool, Lenacapavir stands out among other existing long-acting injectable options due to its biannual dosing regimen. While there is currently no vaccine or single-shot cure for HIV, the global scientific community has made significant strides in developing a range of HIV prevention tools facilitating choices. These include…

Read More

AIDS 2024: The International AIDS conference has unveiled optimistic prospects for an HIV cure

By Avit Ndayiziga It is Monday morning July 22, 2024, in Munich, Germany, at Messe München, a Trade Fair center, and the International Congress Center, a venue that hosts AIDS 2024, the 25th International AIDS Conference organised by the International AIDS Society This conference gathers scientists, policymakers, healthcare professionals, people living with HIV, funders, media…

Read More

With an alarming Hypertension Crisis in Burundi, Dr Ginette calls for a precocious screening to prevent its complications

By Avit Ndayiziga Rising prices in fuel, food, and other necessities have deteriorated the living conditions of Burundians. These harsh living conditions have caused prolonged stressors that fuel hypertension prevalence. However, Dr. Ginette calls for a precocious screening to prevent its complications. In Burundi, especially in Bujumbura, the economic and most populated city of Burundi,…

Read More

Despite a notable decrease in HIV/AIDS prevalence in Burundi, stigmatization persists

By Avit Ndayiziga Even though HIV/AIDS prevalence has significantly declined on a global scale, stigma and discrimination remain significant obstacles in achieving the 95-95-95 UNAIDS targets aimed at ending HIV as a public health emergency by 2025. This message was echoed by Angeli Achrekar, Deputy Executive Director of the Programme Branch at the Joint United…

Read More